PFV and GSK urge stronger action to defeat meningitis in the Philippines

The Philippine Foundation for Vaccination (PFV), in partnership with GSK Philippines, marked World Meningitis Day 2025 with a resounding call: act now, act together, and act faster to defeat one of the world’s deadliest but preventable diseases.

The commemoration highlighted not just the urgency of prevention and early diagnosis but also the often-overlooked need for survivor care. It comes at a crucial moment—midway through the World Health Organization’s Global Roadmap to Defeat Meningitis by 2030.

Meningitis remains one of the fastest-moving infectious diseases, capable of taking a life in less than 24 hours. For survivors, the impact can linger forever—hearing loss, seizures, and developmental delays are only some of the lifelong scars it leaves behind.

According to the Meningitis Progress Tracker, the Philippines ranks 32nd among 194 countries with reported cases, and 2nd highest in the Asia-Pacific region. The weight of this burden is heaviest on children: nearly 40 percent of global meningitis deaths strike those under five years old.

“Despite advances in medicine, the Philippines continues to grapple with delayed diagnosis, underreporting, and limited survivor care. If we want to meet the global targets, we must change the way we respond—through stronger surveillance, faster referral systems, and sustained support for affected families,” said Dr. Lulu Bravo, PFV Executive Director and a pediatric infectious disease expert.

PFV underscores the importance of protection across all ages, but stresses that the First 1,000 Days of life—from pregnancy to a child’s second birthday—are the most critical.

“Meningitis can devastate not only the patient but their entire family and community,” said PFV President Dr. Rose Capeding. “When it strikes within the First 1,000 Days, the damage is often irreversible. Protecting children during this period is not optional—it is a duty.”

GSK Philippines echoed the need for holistic solutions.
“Meningitis cannot be solved by science alone. It requires health systems that can detect cases early, programs that reach the most vulnerable, and partnerships that connect global goals to local realities,” said Dr. Gio Barangan, GSK Philippines Country Medical Director.

Lighting the road ahead
As part of the global “Light the Road Ahead” movement, PFV and GSK joined a symbolic chain of light honoring lives lost to meningitis and survivors who continue to battle its impact.

“For every family touched by meningitis, there must also be hope,” said Dr. Capeding. “Lighting the road ahead is our commitment—to end epidemics, reduce disability, and save lives. No child’s future should be left in the dark.”

PFV is preparing to take the fight to the next level by forming a national coalition with the Philippine Society for Microbiology and Infectious Diseases (PSMID) and the Pediatric Infectious Disease Society of the Philippines (PIDSP). Backed by CoMO’s World Meningitis Day Advocacy Fund 2025, the coalition aims to strengthen policy, build public awareness, and mobilize communities.

Planned initiatives include pushing for a congressional resolution to declare every October 5 as Philippine Meningitis Day, and launching a survivor-led campaign with advocacy toolkits to keep momentum alive.

World Meningitis Day 2025 closed not just as a day of remembrance, but as a rallying cry for action. With only five years left to meet the WHO Roadmap goals, PFV and GSK say the time for fragmented responses is over.

By 2030, the vision is clear: no Filipino child, no Filipino family, should face meningitis alone.

Leave a Reply